- 13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation
- TDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up
- OMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions
- Gilead's US patient access programs for Sovaldi
- Some recent cancer drug prices
- January 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer
- Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP
- Gilead's MPP license for tenofovir alafenamide (TAF) patents
- Hepatitis research and development timeline
- WIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources
Sometime very early Saturday morning, SCCR 21 ended with these conclusions.
Communication to SCCR delegates regarding the beneficiaries of a new WIPO treaty for copyright exceptions for disabilitiesSubmitted by thiru on 12. November 2010 - 11:03
12 November 2010
The delegates to the SCCR are considering various proposals to deal with expanded access to copyrighted works by persons who are blind or who have other disabilities.
The proposal sponsored by Brazil, Ecuador, Mexico and Paraguay would extend the benefits of the treaty, not only to persons who are blind or visually impaired, but also as follows:
This was our 400 word statement at the WIPO SCCR 21.
Statement of KEI at WIPO SCCR 21, November 11, 2010
There should be a compelling rationale for creating new global norms for copyrights.
KEI opposes work on a new broadcasting treaty, and supports work on performers treaty.
KEI supports work at the SCCR on new possible norms for copyright limitations and exceptions, particularly as regards to access to knowledge, and uses of new technologies.
Today, Wednesday November 10 2010, during the 3rd day of the WIPO SCCR21, the Group B presented a proposal for a Work Program on copyright exceptions and limitations for the WIPO SCCR. Group B is the negotiation group that groups developed countries like US, EU, Switzerland and others.
The proposal is available here
The following proposal for a road map for the SCCR's consideration of limitations and exceptions was submitted by the African Group on Tuesday, 9 November 2010.
(Limitations and exceptions)
Bearing in mind
- the Development Agenda recommendations;
SAVE THE DATE (10 November 2010): What should the WIPO SCCR do about limitations & exceptions: the way forward?Submitted by thiru on 9. November 2010 - 9:50
On 10 November 2010, Knowledge Ecology International will hold a side event from 13:30 to 14:45 in the Uchtenhagen room at WIPO which shall address the question, "What should the WIPO SCCR do about limitations & exceptions: the way forward"? Speakers include representatives from the Centre for Internet & Society, Egypt, the International Publishers Association, KEI and the South Centre. This is an open event. Please see below for details.
What should the WIPO SCCR do about limitations & exceptions: the way forward?
Invitation to the KEI side bar event
SCCR 21: General statement of Group B (covering broadcasting, AV protection and limitations and exceptions)Submitted by thiru on 9. November 2010 - 0:18
The following general statement was delivered by France, on behalf of Group B, on the first day (8 November 2010) of SCCR 21.
Group B opening statement
I thank you M. Chair,
Group B is glad to welcome you back in Geneva for this 21st session of the Standing Committee on Copyright and Related Rights, which we hope will be a productive one.
The 21st session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) commenced its work at 10:33 AM on Monday, 8 November 2010.
This unusually quick start is perhaps indicative of Member States' commitment to examine the three substantive agenda items up for consideration during this five day negotiation; these three issues include: 1) protection of broadcasting organizations, 2) protection of audiovisual performances and 3) limitations and exceptions.
Global Fund calls upon drug companies to "share without delay" AIDS drug patents with the Medicines Patent PoolSubmitted by Judit Rius on 5. November 2010 - 9:44
In a October 7, 2010 letter, Professor Michel Kazatchkine, the Executive Director of the Global Fund to fight AIDS, Tuberculosis and Malaria, has written to Dr. Jorge Bermudez, the UNITAID Executive Director, to discuss the Medicines Patent Pool.
Kazatchkine congratulates UNITAID for the announcement that an agreement had been reached between U.S. National Institute for Health and the Medicines Patent Pool for the voluntary license of the NIH patents rights on an HIV-AID drug, Darunavir.
The European Generics Association has written to the European Parliament asking that patents be removed from the Anti-Counterfeiting Agreement. A PDF copy of their letter is here. The text in html follows:
MEP Mr. Gianluca Susta
1049 Bruxelles- Belgium
Brussels, 5th of November 2010
Ref. EGA comments to the consolidated text on ACTA that reflects changes made during the
September 2010 Tokyo round1.
Dear Mr. Susta,
The following statement is the oral intervention made by USTR at the WTO Council for TRIPS (October 2010) regarding ACTA.
Talking Points of the United States for TRIPS Council Meeting of October 26, 2010
Agenda Item P
We would like to thank other delegations for their interest in the Anti-Counterfeiting Trade Agreement (ACTA).
Delegations will recall that the United States and other delegations have been interested in discussing the issue of IP enforcement at this Council for many years and so we’re pleased to have another discussion today.
The following statement was delivered by USTR at the WTO Council for TRIPS Annual Review of the Paragraph 6 System on Wednesday, 27 October 2010.
Agenda item F, Annual Review of the Paragraph 6 System
We are pleased to be here today to participate in the annual review on the implementation of paragraph 6 of the Doha Declaration.
On November 2, 2010, U.S. Senator Bernard Sanders (VT-I) sent a letter to Margaret Hamburg, the FDA Commissioner, urging the agency to review the ethical implications of the 12 years of marketing exclusivity created by the Biologics Price Competition and Innovation Act of 2009 (BPCI Act).
Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilitiesSubmitted by thiru on 2. November 2010 - 11:50
The following statement was delivered on Wednesday, 27 October 2010 by the UNAIDS Secretariat and on behalf of UNDP during the Annual Review of Paragraph 6.
World Trade Organization
Council for TRIPS – Regular Session
Annual Review of Paragraph 6
Doha Declaration on the TRIPS Agreement and Public Health
Agenda item 4 – Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Remarks by UNAIDS Secretariat and on behalf of UNDP
27 October 2010
Mr Chair, Distinguished Delegates